In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin. 1986

G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro

Neutral and negatively charged liposomes containing Adriamycin (ADM) were examined for efficiency of drug entrapment and stability in serum. The greatest entrapment of ADM was obtained with negatively charged liposomes containing sulfatide. Moreover, these sulfatide-containing liposomes were more stable than other liposomes in the presence of serum. Tissue distribution studies indicated that the levels of ADM were increased several-fold in mouse liver and spleen after i.v. injection of the drug entrapped in sulfatide-liposomes, while levels of the drug were significantly diminished in the heart. Finally, the in vivo antitumor activity of ADM in liposomes containing sulfatides resulted in significantly greater survival rates than free ADM or ADM entrapped in liposomes without sulfatides.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013433 Sulfoglycosphingolipids GLYCOSPHINGOLIPIDS with a sulfate group esterified to one of the sugar groups. Sulfatide,Sulfatides,Sulfatoglycosphingolipids
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
January 1989, Advances in enzyme regulation,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
July 1988, Biochemistry international,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
December 1979, Biochemical and biophysical research communications,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
October 1986, Biotechnology and applied biochemistry,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
May 2005, Archives of pharmacal research,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
June 1989, Nihon rinsho. Japanese journal of clinical medicine,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
October 1992, Biochemistry international,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
November 1987, Life sciences,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
January 2000, PDA journal of pharmaceutical science and technology,
G Cervato, and P Viani, and I Galatulas, and R Bossa, and B Cestaro
August 1986, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!